Living with a rare lung condition can be especially challenging, but research into interogran cross talk and organoid models, and cross-border registry are improving outcomes.

US CDC Records More Than 3,100 Measles Cases So Far in 2026

The U.S. Centers for Disease Control and Prevention said on Friday there were 3,134 confirmed measles ⁠cases in the country so far this year, marking the highest annual...

Holistic Care Must Be Standard in Lung Disease

Experts at ERS 2026 urge clinicians to treat the whole person rather than just damaged lungs, moving from mere symptom control to focus on what matters most to each patient.

CPAP May Offer Enhanced BP Benefit in Sleep Apnea & Insomnia

Patients with both insomnia and obstructive sleep apnea may represent a clinical phenotype characterized by an enhanced systolic BP-lowering response to continuous positive airway pressure therapy.

Australia Confirms First H5N1 Bird Flu Case in Local Mammal

Australia on Sunday confirmed its first case of H5N1 bird flu in a mammal, with the deadly virus ⁠found in a long-nosed fur seal in South Australia state.

Nerandomilast Lowers Mortality Risk in Pulmonary Fibrosis

Nerandomilast is associated with reduced mortality risk in patients with pulmonary fibrosis, a pooled analysis of two trials shows.

Mastering the HER2 Spectrum for Individualized Management of Advanced/Metastatic NSCLC

Expert Insights on the Next Wave of IO Combinations in mNSCLC

Treating Advanced Disease With Bispecific ADCs: Mechanisms of Action and Therapeutic Rationale for Bispecific ADCs in Solid Tumors

New GLP-1 Concern; FDA Sued by Health Groups; Over 750 Dead in Ebola Outbreak

Health news and commentary gathered by MedPage Today staff

Wildfires Expose Millions in the Midwest and Northeast U.S. to Dangerous Smoke

States warned residents about air quality issues that could last for days

Nerve Stimulation for Sleep Apnea Linked to Some Long-Term Heart Benefits

But the higher risk of hypertension and cardiovascular events within 2 years was unexpected

Wildfire Smoke Kills Tens of Thousands Each Year. Here's How It Attacks the Body.

"It's a big giant toxic soup of particles and gases," expert says

Novel Antifungal Shows Activity in Valley Fever

Three-quarters of patients had a clinical response in mid-stage study

FDA Greenlights Next-Generation ROS1 Inhibitor for Lung Cancer

Zidesamtinib is indicated for patients who received a prior ROS1 inhibitor

Reproductive Health Should Be Emphasized in Cystic Fibrosis Care, Foundation Says

Clinicians should initiate annual discussions

Recommended News For You

Scream, It's Good for You; Release the Cancer Pigeons; Talk of Chemo Rationing

Patients With Early-Onset Cancer Unaware of Infertility Risk

Diagnosis of Mass Confined to the Kidney: Is It RCC or TCC?

mRNA-based COVID vaccines generate improved responses to immunotherapy

Marstacimab Gets FDA Nod for Hemophilia A or B Without Inhibitors

FDA Bans Red Dye No. 3 From Foods, Ingested Drugs

C/EBP? works in tandem with MYB to sustain AML cells' oncogenic program.

Whats more on Hidoc Dr.

Medical Updates

KOL Videos

Surveys

Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world

Featured News

Featured Articles

Featured Events

Featured KOL Videos

1.

Cancer After Weight Loss; How Older Adults Use the Healthcare System.

2.

Mortality up for children with leukemia from lowest SES neighborhoods

3.

Response Duration After Stopping Enfortumab Vedotin in Bladder Cancer

4.

Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC

5.

Trial Supports Ivonescimab and Chemo for NSCLC Survival

1.

Emerging Therapies Through Personalized Tumor Ecosystem Remodeling

2.

Clinical Guidelines for Neutropenic Complication Monitoring

3.

Novel Antibody Conjugates in Cancer: Mechanisms, Clinical Evidence, and Therapeutic Implications

4.

Platelet Dysfunction During Severe Systemic Inflammation: Mechanisms, Clinical Implications, and Emerging Therapeutic Approaches

5.

What is Mullerian and How Does it Affect Your Health

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

1.

An In-Depth Look At The Signs And Symptoms Of Lymphoma

2.

Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals

3.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV

4.

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC

5.

CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

COPD activates bitter taste receptors, the target of asthma treatment

Latest News

Bridging the ROS1 Divide: Translating Biomarker Insights and Therapeutic Advances Into Community Oncology Practice for NSCLC

Innovations in NSCLC: Outlooks on Clinical Trials and Emerging Bispecific ADCs

My Job Has Become Mounds of Paperwork. Work Requirements Will Make it Worse.

FDA Says Juul Can Sell Updated Vaping Device With Age-Gating Technology

FDA Approves Four Updated COVID Shots Targeting XFG Variant

Doctors Groups Offer Updated Flu, COVID Vaccine Recs to Ease Confusion

Todays Updates

ASTRO: American Society for Radiation Oncology